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nJT30DUCT ION

Scarlet Fever has prolJa"bly caused more wide spread
interest throu3h

atte~pts

at its prevention and serum

treatment than any other infectiollS disease.

However,

in no other infectious disease has there been so much
controversy among practitioners and at the same time
such unanimity of opinion in the reports of experienced
observers.

Much of the work '.vi th serum therarY haYing

been done "before adequate methods were adopted for preparation, standardization and administration of the serum
may account for some of the unfavora"ble res 1)lts.

Recent

80nd careful investii.sators are much of the same opinion
now in regard to the nse of serum in the treatment of
this disease.

Among the general practitioners and some

teachers of theraDeutics there is still dou"bt as toorac~

.~

tical use of the serum.

Because of tilis existing contro-

versy, I have chosen "The Serum Treatment of
as my

SU~Jj

ect.

SC~l"-'let

Fever"

By a survey of the 1 i terature on t'1i s

topic, I hope also to "be the better enabled to decide on
the meri ts of such treatment and to
led;e concerning its indications aYld

g~lin

practica.l kYlOW-

ad~inistration.

In a study of any disease one of the most interesting
phases is its history,
a "brief

hi8toric~1

["'),:ld

s~Gtch

for that re'-'tson I have included
of Scarlet Fever.

(1)

D}5:B'rNITI01~

Scarlet Fever (44) is an acute infectious disease
caused by Streptococcus scar1atinae, and is characterized by sore throat, a diffuse scarlet rash and the frequent occurrence of a variety of complications and sequelae.
The disease process consists essentially in a primary local
infection from which a specific toxin is
tri~uted

by the blood stream.

self-limited in duration.

It

a~sorbed,

and dis-

The specific toxemia is
~ives

rise to a series of

symptoms, of which the rash is the most characteristic.
The most important complications are of a seDtic nature,
and are due to a spread from the primary lesion.
seqne1ae, of

w~1.ich

The

acute nephri tes is the most stri king,

occur durincs convalescence ao!)ut the t1<li rd or -f'ourth week
of the disease.

The course and severi t:r of the seq'le1ae

seem to be strikingly independent of the severity of the
primary illness.

HISTORY

The works of Galen, Rhazes and other ancient writers
contain various descriptions of a disease with throat
symptoms and a diffuse red erllption slqgesting scarlatina,
but not until the sixteenth century was the disorder
-2-

differentiated from measles by Ingrassias, of Naples.
The first accounts of what appears unmistaka'bly to be
scarlatina are those of Daniel Sennert, of Wittenberg,
and his son-in-ltlW, Ivfichael Doerring, about 1625.

They

give us the typical descrlption of scarlatlna, the rash,
desquamation, joint pains, anasarca. and delirium.
Synde~~am

in 1776, however, was the first to present a

careful analysis of the disease with its medical characteristics and to
scarlet fever.

~ive

it the

desi~nation

scarla.tina or

He a.lso differentiated it from measles,

with which it was constantly being confused.

The epidemic

7rhich gave Sydenham the opportuni ty for studying scarlet
fever in large mmrbers was -eYidently a mild one, since
he believed the disorder scarcely deserved to be considered a disease.

But he was destined to change this

"belief fifteen years later ;rihsn an el)idemic of

unusu~,l

malignancy, described by Morton broke out in Engla:'ld.
Huxham (1740) appears to have been the first to call attention to the importance of angina in the symptom complex of scarlet fever (22) (5l)w
The disease was common in Europe during the eighteenth
century and from the middle of the era spread over "both
hemispheres.

According to Gaiger, it first appeared in

the North American Colonies in 1735, spreadin3 over New
England, reaching New York in 1746, thence extending to
the coast states.

By

1791 it made its appearance in the
-3-

interior, reaching Canada and the Northern States during
the early :part of the nineteenth cent1lry.

South

Am~rica

1;vas not invaded until about 1830, and sinpe then the
disease has appeared often and at times in severe epidemic
form, in nearly all of the countries of that part of the
continent.

During the middle of the nineteenth century

scarlatina was reported from Polynesia, New Zealand, Tasmania, Austrailia and in distant Greenland and Iceland
(51) •

The recent history is more important from a standpoint
of etiology.
In 1885 Crooke reported the presence of streptococci
in the blood and or3ans in fatal cases of scarlet fever,
and Loeffer obtained streptococci from the throat in scarlet fever, isolating the organism in pure culture.

More

striking were Kleins investigation of a milk born

epid~mic

of scarlet fever in Dendon near London in 1885.

He iso-

lated streptococci in pure culture from a lesion in the
udder of the cows, and also isolated similar streptococci
in pure culture from the blood of scarlet fever patients
during life and after death.

He reproduced ulcerative

lesions in cows with pure cultures of the human blood
culture strains.
latinae.

He named the

or~anism

Uicrococcl1S scar-

In 1,399 Class, and in 1900 3aginsky and SOITL.'Tl.er-

field described the regular presence of streptococci in
the throat, early in

sc~rlet

fever.

-4-

The former infected

swine

~ith

these organisms and

r3>sh in these animals.

o~served

a scarlatina form

Corroboratins Klein, He'Ktoen in

1903, Jackman in 1905 ~l,nd others found streptococci in

the hlood cultures during scarlet fever.

In 1903 Schott-

muller introduced the method of eli fferentia tin~ betw'een
hemoiytic and non-hemolytic streptococci.

From then on

it was found that it was the hemolytic streptococci which
was so frequently associated with scarlet fever.

Moser

in 1902 and Savcheska in 1905 ir1IDunized horses with streptococci obtained from scarlet fever patients in order to
produce a therapeutic serum.

The serums of both investi-

gators were used with a certain amount of success but the
'fa"ITorable results could not be duplicated ge:1erally and
the use of the sernm was

a'Ja~1doned

(44).

In 1905 ,Tockmann p'l'Jlisned a re"ITie-n of the work done
along these lines and examined the claims made that the
hemolytic streptococcus so frequently fonnd in the throats
of scarlet fever patients was the causative aJent of the
disease.

He came to the conclusion that a good case had

not been made out and that this streptococcus was not the
causative agent':)ut a secondary invader (36).
In 1907 Gabrichevski published the results of his
"fork wi. th a vaccine of killed cultures of streptococcus
scarlatinae.

He and his co-workers found that a large

proportion of children inoc 1)lated wi th the vaccine developed a marked erythefllia simil:'u to locali7.ed scarlatin9,e
-5-

rash and that a smaller proportion developed a train of
symptoms indistinguishable from scarlet feyer.

On sub-

sequent inoculation in the same subject reactions were
less marked or absent.

Gabrichevski held that his find-

in,];s clearly indicated t'u'3..t the sc"'slet fever stre}Jtococcus
was a specific or,ganisIn, that his res;Jlts, taken with the
fact that streptococc '"vere usually not obtained in blood
cultures early in scarlet fever, proved tha.t the disease
was a specific toxemia, and that streptococC 11S scarlatinae
was the cansative

aL~ent.

Although his method of vaccina-

tion was used for a time in Russia with apparent success,
his work was not carried further, but was over-looked or
sliE~hted,

until q ite recently.
1J

7Tork on the sl1b,ject then

lapsed and no important advance a.iJpears to have been made
for some ten years.
In 1917 Schultz and Charlton, experimenting with
serum from convalescent cases of scarlatina, found that
t~li

s serum, when inj ected into the skin of acute cases of

the disease, while the rash was well market, caused complete blanching of the rash in a small area at the seat
of injection.

They also found that the Sertlm from some

healthy individuals produced this result, whereas the
serum from cases in the early stf:lge of scarlatina did not
possess this power.

This was a great step in advance,

but was not so recognized at that time.

In 1923 IvIair

repeating these experiments of Schultz and Charlton
-6-

explained this rea,ction thus:

"ScClrlet fever is ap1JClT-

ently a seneral toxaemic), and the rash only a rm.nif'estation
of the toxin uni ting wi th the

tis~me

cells causing a capil-

lary dilatatj_on with swollen panillae.
ne~ltralizes

The serllm injected

the toxin in the tissue and causes the disap-

pearance of the rash.

The neJative reaction of the sera

of acute cases of sC8.rlet fever is simply due to the fact
that antitoxin has not yet developed (44).
In 1919 Dochez, Avery and Lancefield devised a new
method for the differentiation of
tic streptococci.

types of hemoly-

bilo~ic

This led to a further study of the

hemolytic streptocotcus so constantly found in the throats
of scarlatinae patients.

~eports

by Dochez and 31iss (19),

Tunnicliff (46), and Stevens and Dochez let to the conclusion that this hemolytic streptococcus was a specific
type.
ne~ative

In 1916 Dick and Dick (10) obtained
in a

serolo~ical

study of the

or~anisms

throats in scarlet fever patients.
inoculated human yolunteers

'ivi th

results

found in the

In 1921 they (11)

the various orgcmisms

derived from scarlet fever patients.

Streptococcus scar-

latinae was probably among these bacteria.

Some of the

volunteers contracted a sore throat but none developed
scarlet fever.

In October 1923 the same 70rkers (12)

published a second series of inoculation experiments in
human volunteers with successful results.
-7-

A culture of

hemolytic streptococcus, isolated from the infected finger
of a scarlet fever patient was swabbed on the tonsils and
pharynx of five individuals.

After forty-eight hours one

developed a mild but typical attack of acarlet fever; one
had merely a sore throat and fever; three rem.ained well.
Ey intracutaneous tests in human volunteers Dick and Dick

(13) soon demonstrated a

hi~hly

potent toxin in bacteria-

free culture filtrates of streptococcus scarlatinae, the
toxin which ·}a-brichensld had found in his vaccine of
killed cultures.

They then developed a number of new im-

portant facts regarding this toxin which they showed to
be scarlet fever toxin.

In January 1924 they (14) de-

scribed a skin test for susceptibility to scarlet fever,
performed by intracutaneous injections of a standard amount
of toxin.

They(15) showed that an individ 1)al, picked by the

test as susceptable, developed scarlet fever on experimental inoculation with streptococcus scarlatinae, while
another control individual picked by the test as immune,
remained well when similarly inocnlated.

They (16)

neutralized the toxin in vivo and in vitro by convalescent human serum and also with the serum of actively
immunized huma,n volunteers.

They(l?) found that individ-

uals, susceptable by their test, could be actively immunized
with injections of toxin and these

individu~ls

then

re~

acted negatively to the test and were immune to scarlet
fever.

In fact a series of 360 susceptiole nurses a~1d
-8-

internes actively immunized with the toxin, did not contract scarlet fever on subsequent prolonged exposure, ten
per cent of a control series of 240 nurses and internes,
not tested or immunized, developed scarlet fever on sirnilar
exposure.

From this time on, the etiology of scarlet fever

having been well established, most efforts

we~e

made to

produce therapeutic serums for treatment and prevention.

SERillill: THERA?Y

All efforts to identify and isolate the specific
cause of scarlet fever having fA.iled, it had

~')een

impos-

sible to produce an immune serum for therapeutic purposes
in this disease similar to that employed in the treatment
tetanus, diphtheria, epidemic meningitis and pneumonia.
However, it was naturally inferred that persons who had
recently passed through an attack of scarlet fever would
have specific antibodies in their blood, and should the
antibodies be in sufficient concentration, that the serum
of such blood might be of curative value when introduced
into patients acutely sick with the disease.
Acting on this presnmption, Weisoecker in 1897,
treated five cases of scarlet fever with the blood serum
of convalescents, but with little success.

From 1897

to 1903 scarlet fever cases were treated by injection of
-9-

convalescent serum

"by

Rumpel and Scholz.

lIuber and Blumenthal, Vcm Leyden,

They did not reach any ceitain conclusion

as to the value of the procedure.

The serum was injected

subcutaneously and in relatively small doses.

Because of

the absence of any decided advantage from this treatment
and from the fear of transmitting syphilis and other infection the use of convalescent serum was
a"!)out ten years.

aban~oned

for

By this time the 'YEtSSermann test made

it possi ')le to exclude syphilis from the donor of the serum, and experience in the administration oflarJe quantities of serums had been acquired.

:ntrav"enous injection

of serum had also been successfully employed in 'Tarious
cases.

In 1912 Reiss and Jungmann treated twelve cases

of severe scarlet fever by intravenous injections of 40
c.c. to 100 c.c. of convalescent serum with marked benefit

in ten cases.

They drew the blood from convalescents about

the end of the third or

beginnin~

of the fourth week of

the disease, tested each serllm for syphilis and sterility
and mixed the serums from several persons, since some persons seemed to yield
others.

lar.~er

amounts of antibodies than

The next year Kock reported from the same clinic

the treatment of twenty-two additional cases with one
death.

He emphasized the value of early administration.

He noted a prompt fall in fever nSll.ally followed 0y a
slii~ht

rise, and he was espec ially impre ssed "b:r the rapid

and marked. imnroveme!lt in the general condition of the
-10-

patient.

In 1915 Reiss and Herts, Rnd Kock reported still

larger series of cases in which the results were most satisfactory (49).
In April 1915 Zingher (53) reported the treatment of
scarlet fever with fresh blood from convalescents.

In the

fall of 1915 he reported the treatment of fifteen cases of
very severe scarlet fever selected from 900 cases, with
4 deaths.
Zingher t s method consi sted in o"btaining fresh hUI'18,n
blood (convalescent or normal) from a p8,reC1t or near relative, by means of a 30 c.c. record syrinJe and a needle
inserted in the median cephalic vein at the bend of the
el"'oow of the donor.

The required arlOunt is

rcq~lidly

as-

pirated and i:rnmediately citrated by adding the blood to
a 10 per cent sodium citrate solution in the proportion
of 30 c.c. of blood to e80c11 c.c. of citrate sol1Jti6n,
making a 0.33 per cent final dj.lution of the citrate.
When the syringe is full, it is detached from the needle
which is not removed, but is kept in place by an assistant
who attaches to it a 5 c.c. record syringe containing a
1 per cent sodium citrate solution to keep the needle free
from hlood.

In this way three or four syringefuls of

blood can be obtained before it
out the larze

syrin~e

~ecomes

necessary to wash

with sodium citrate.

collected in 100 c.c. bottles, each of
c. c. of sodium citrate solu"tion.
-11-

w~ich

Ihe blood is
contains 2

To each t)ottle 60 c.c.

of blood are added.

This is then s.haken to distrib'Jte

the sodium citrate.

The required 8.IDOunt, 120-130 c.c.

can be thus obtained in less than ten minutes.
The recipient is given

intra~lscular

injections of

the blood (at one sittin~ into the triceps, the lateral
region of both
~ions;

thi~hs,

the calves and both sluteal re-

the dosase ')eing 15 c.c. for a youn'.; child and

30 c.c. for an older child or an adult, at each of the
three sites of injection.
Two of the patients died from septic conditions,
and the other two patients who died were mo!'i 'ound "vhen
they were received.

Of

tb~

11 patients who recovered, 5

were of the purely toxic type, the other 6 had additional
se:ptic complications.

The 5 nnrely toxic cases shoYved a

cri tical drop in tempera tnre after vfhich it remained normalar slightly above normal.

In the 6 remaining cases

the drop in temperature was less marked and was followed
by a secondary rise which persisted for a numl)er of days.
In 1918 Weaver (49) reported the treatment of 19
cases of severe scarlet fever selected from the cases
that entered the Dnrand Hospital by use of the convalescent serum.
Zingher.

His method was similar to that used by

The blood was drawn on the 20th to 28th day,

using convalescent patients that were'free from S11spicion
of tuberculosis and had nesative 'Yassermannts.

The serum

from several patients were mixed, tested for sterility,
-12-

Rnd stored, until used, in the refrigerator in portions
for a sinJle dose.

The serum was injected intrarnlscularly

in doses of 25-90 c.c., 60 c.c.

bein~ t~e

usual dose.

His

results were favorable and coincide yith those of Zingher.
Weaver (48) aJain in 1921 reports the treatment of
54 cases of scarlet fever, 38 of the toxic type and 6
septic complications, by use of intramusc ')lar ser1Jm from
convalescent patients.

His results were very conclusive,

Two of the patients died, one septic and one toxic, both
bad risks.
He presents charts showinJ the best drop in temperature curve in those cases that 7lere ,.;iven serum earliest,
Fourth week serum was preferred by him.
was found to be still

activ~Mixed

Seventh week serum

sero were best liked,

D,inors ha,vj,ng mild attacks gave just as an efficient serum
as those with severe attacks.

Serums several months old

were not as efficient as fresher serum.

Bernba:lm (2) in

reviewing the Ii terature reports th8.t Jvl. J. Synnott, l\few
York, s 1 lccessfvlly treated one case desperately ill, 'I'li th
citrated convalescent blood.

Temperature fell by lysis.

lIoyne reports its successful use in the contagious hospi tal of Cook County.

C. Klin,,; and G. ';lidfel t, Stockholm,

report the epidemic of scarlet fever that passed over the
c1 ty of Stockholm in 1916-191?, 'vhen 2,165 cases 'lITere
reported, showed a very large percentage of severe and
fatal cases.

Treatment of the severe cases by the serum
-13-

method prepared from convalescents was undertaken and showed
excellent results.

3efore the serum treatment was attempted,

the fatal cases of the severe form were 50 per cent or more.
Of 237 cases treated, 195 proved successful and the percentage of deaths declined to 19.5 per cent in

~ecember

and 6.3

per cent for January, although the relative number of severe
cases had increased.

7he serum prepared from the blood of

convalescents 'lias found to be of equal value as taken from
liJht, medium or severe form.

The blood

~rvas

usually taken

from the fifth or sixth week after the first appearance of
the disease, l)t1.t Vias found effective when taken the fourth
or seventh w'eek.

:::-1eal thy donors '!,rere selected.

l~o

second-

ary ill res'..ll ts were noted from the use of the sernm in any
case.
W. Schult/je, Germany, reports serum therapy was employed in 184 cases, the injection being either normal
human serum, convalescent serum or mixtures of both.
:F'avora:jle result s were secured, larger d)ses .;i vin~ the more
definite improvement in the condition.

1he serum should

be given within the first three days of the disease.
H. F. Prinzing, Berlin, 1918, states that in patients
1i'Tho

had not received serum therapy, the disease

71£1S

fol-

lowed l)y lymphadeni tis in 34.6 per cent, oy oti tis media
in 10.8 per cent, and by glomeruler nephritis in 18.9 per
cent of the cases.

These conditions appeared in patients

who had received serum in per cent of 15.9 - 9.3 - 8.2.
-14-

':7. Grissback, 3erlin 1919, reports thg.t i::1'

Sl.

study

of 21 cases, human serum 'vas injected in 19 cases from
convalescents, i::1 two from normal i::1dividuals; 10 to 20
c.c. were given each patient.

He

~tates

qThe

treat~ent

is very efficient in modifying the duration and severity
of the disease.

~he

reactions following injecti6n of serum

Are dan:;erolls."
B. 3ernbaum (2) reported 39 cases by Dr. Levy at the
meetin~

of the Detroit Pediatrics Society in the Hospital.

Thi s 'Nas the number of cases treated at the Herman Fiefer
~losrli

tal wi th convalescent SentI'! for the year
Thirty-two lived and seven died.

1, 1921.

July

e~1ding

Of the seven

who died, t",VO were practically morL')und, one died within
21 hours and the other 18 hours after entrance: one after
ei~ht

days of acute hemorrhagic nephritis, one after eight

days of septic complications.

Three died of toxemia.

Two

of these received but 10 c.c. of serum and one 20 c.c.
Of the 32 who lived, 20 were toxic cases and 12 had
Sel')tic complications.
35 c.c.

The average dose was from 10 to

intra~lscularly.

The serum was administered from

the third to the eighth day of the disease.
sponded

G,S

',vell as adul ts.

Children re-

:Ei;.:;h teen case s were treated

so far the fiscal year, beginning July 1, 1921.

These were

the most severe of all cases of scarlet fever admitted
since that date.

Of the 18, 5 died.

The blood was

ta~en

from healthy donors in the fourth or fifth week of disease.
-15-

Snow and Fairbairn (37) in 1923 reported the cure
of a grave case of scarlatinal sepsis 'Nith complications,
in a. boy twenty-seven months old, by a blood transfusion
from a six month's convalescent donor.
Dochez (20) of New York described, in January, 1924,
an antitoxic serum which he had produced in the horse by
adopting a most inJenious method.

In order to protect

the streptococcus from the phagocytic action of the
leucocytes of the horse he injected liquefied agar subcutaneously into the horse f s neck, and 'vhen the
cooled and solidified,

livin~

were injected into the aJar.

-

~Irvived

a~ar

had

Streptococci scarlatinae
Thus protected the orzanisms

and produced toxin which was taken up by the

l)lood stream.

After a course of i1'l'1.Inunization of six

months the horse was bled and the serum tested in the
cases of scarlatina.
Emplo;rin,~

this antitoxic sarurn, 31ake, Trask, and

Lynch (3) obtained very good reS'll ts in
cases of sc;)'rla tina, a

sin~5le

t~1.e

treatrlent of

intramuscular inj ection

of the serum in early cases jeing followed by prompt disappearance of the rash and symptoms of toxemia and a very
rapid convalescence ,,'Vi thout complications.

They f:nmd

also that the serum, injected intradermally in cases with
early scarlatinal rash, caused complete blanchinJ of the
rash at the seat of inj ection (Schul t:;>;-Ch8,1"'1 ton reaction).
They also demonstra.ted that t':1e toxin circulg,ting in the
-16-

Blood of acute cases of scarlatina is completely neutralized
wi thin a few hours R.fter the inj ecti on of Dochez' s serum.

They showed this hy bleedin;; the patient inu:nedi8"tely 1)efore treatment and 0'0 aininJ positive Dick

s~in

reactions

in suscepti ~')le indi vidn8.1s, g,nd ')y aTlin 'oleeding at frequent short intervals after inj ection of D·)chez' s serum.
Even in some very toxic cases the Dick tests were negative
as early as four hours after the administration of the
serum.
In A"pril, 1924, the JhCKS (17) reported the prod'lction
of an antitoxin in the horse by a different method.

Their

methods as descrihed by them is as follows:
"The Strains of hemolytic streptococci that caused
experimental scarlet fever in human 1)eings yield toxin of
practically the same stren1th in all different lots, so
that it is not necessary to standardize accurately
prepared from these strains for immunizing horses.
"Flasks of plain broth, containing I per cent sterile,
def i or ina ted sheep f s blood, are inoc11l8, ted vri th pure c')ltures of the hemolytic Streptococci.

Onr first horses

were immunized with toxin obtained from plain broth cllltures,; l:mt wi th a small amount of 'blood in the broth, the
toxin is somewl'la t stronger.
!

We ha7e used hr oth p:-e}Jared

with 7itte's peptone, 1 per cent, and
tr8.ct, 0.3 per cent.

Lie~i3's

meat ex-

After six days incubation, the cul-

tures. are filtered thrOl.1 ~h filter -;18,})er until clear, and
-17-

, a "DDer 1Kel e Id f"lte1"
\,nen :pas se d t'n.rouJn
.1"
•

.!-,

'_","'
A
u_

.<'

st.Arl"ll"t~{
~ - .
._

of

the filtrate is determined by cll1tllTe, and it is Kept in
the refri:;;erator.

Care must

~Je

taken to discard any con-

taminated flasks before filtration.
inj ected snocutane )usly
ginning with 20 c.c. and

in:~radually

increasin~

The sterile toxin is
increasin,s doses, beto 1 liter.

The horses

are then continued on injections of about 1,000,000 skin
test do ses of the undi1 11ted toxin every five days.
"The sterile toxin does not
horses r.enLain in

:~\Jod

ca~se

abscesses and the

condi tion •. After prelininary tests

show that the horse is producing a good antitoxin, it is
bled, and the serum or plasma is concentrated.
centration is essential, not

bec~use

The con-

the antitoxin content

of the unconcentra.ted serum is not high enou:;h, but to
avoid unnecessarily frequent and severe sernm re('l.ctions.
"An amount of scarlet fever toxin corresponding to
1,000 skin test doses is capa'ile of causing general malise,
nausea, vomi tinz,

p.

fever of 101 degrees F. and a general-

ized scn,rla tinal rash in suscepti "jle '],d1) 1 ts.

In oPler

words 1,000 skin test doses of toxin, if injected without
previous immunization, prodllces a c11nic8,1 condi tion resembling a mild attack of scarlet fever.

We have

ta~en

the amount of antitoxin required to neutralize t"lis dose
of toxin as a

~asis

fever antitoxin.

for the standardization of scarlet

Any antitoxin used should "be of such

strength that 1 d.c. of the concentrated serun will
-18-

'Nill Jleutralize 1,000 skin test doses of the toxin.
is

possi~le

to obtain serum

considera~ly

stronger than this

minimum requirement of potency.
"Method of Standardizing Antitoxin:
"For

standardizin~,

the concentrated antitoxin is

d1lu.ted I to 10 in sterile 'Ph;rsiolo:",;ic sodium chloride
solution.

Two cubic centimeters of this diluted antitoxin

is mixed with

~

c.c. of

8.

toxin solution.

-'-he solution

of toxin used is 10 times as strong as the standard skin
test solu.tion, so that each cubic centimeter represents
100 skin test doses.

"Tv>/'O control solntions are made, one of equal parts

of toxin and salt sollltion, the other of' equ8l parts of
the diluted toxin and salt solution.
are

incu~ated

one hour.

These three mixtures

Skin tests are then made with

0.1 c.c. of each mixture in persons with positive to

strone;ly positive skin reactions.
positive reactions are not

Persons 'vith sli:shtly
for these tests.

accepta~le

"On observation, at the end of twenty-four hours, the
test made wi th the anti toxin alone ShOll.ld be nega ti ve.

If

this is positive, the person is sensative to horse serum,
and is not useful for the standardization.
..
• .+. •
the toxin alone should be gosll,lve.

toxin-antitoxin mixture will be

£he test with

The test with the

neg~tive

if the

a~titoxin

is sufficiently strong.
"At the end of forty-eiJht hours,
-19-

anoth~r

observation

is made.

The 'lVeaker anti toxin, like convalescent serum,

rna:! hold the toxin in com.bination twenty-four hours, but
release it after that so that the toxin-antitoxin test that
was negative at the end of twenty-four hours may be found
positive at the end of forty-ei3ht hours.
'''For further standardb:ation, the same teets are repeated with higher dilution of the antitoxin.
w;ie decided to employ as a therapeutic dose an amount
of antitoxin sufficient to neutralize twenty times the
quanti ty of tOlxin kno\I'{TI to produce the characteristic
symptoms of scarlet fever in ad11l ts.

}i'or convienience we

speak of this amount of antitoxin which neutralizes 20,000
skin test doses as a therapeutic dose.

Each patient in the

antitoxin series received one such dose, and in a few of
the most severe cases, two therapeutic doses were given.
"In their conclusions they state that injected intramuscularly, the serum '1lanch'3s the !'8.sh, lowers the temperature and improves the general condition of scarlet
fever patients.

If given early it shortens the course of

the disease and incidence of complications, and sequelae
is greatly diminished.

One therapeutic dose, as described

above, suffices in early cases of moderate severity."
'?li th the production of the DJchez serum a.nd that of

Dick and Dick numerous inveGtigations were made immediately
concerning their merits.
In May 1925 Thene:)ee (40) repor+.,s favoral')le resnl ts
-20-

from the use of Dochez t s antiscarla tinal serum ;)y intravenous inj ec tions.

In September, 1925, J:'heneo.ee (41)

reports further observations on administration of Dochez's
antitoxin in the treatment of forty-two patients.

In this

series of patients he used ':Joth concentrated 8nd unconcentrated antitoxin, by intravenous and intramusclllar injections.
Se states that the unconcentrated antitoxin is the safer
procedure for intravenous administration,

'rrfli1e

the concen-

trated anti toxin is safer for intramuscula,r inj ection.
3lake, Lynch and frask (3) and 3lake and Trask (5) in
October, 1925, reported the treatment of 57 cases of uncomplicated scarlet fever; 48 cases of scarlet fever with
septic complications, and seyen cases of post-scarlatinal
sepsis, with Dochez's unconcentrated antitoxin by intramlscular injection.

The 57 uncomplicated cases were all

promptly cured 'Ni thin 12 to 36 hours irrespective of the
severity of the disease at the time of treatment.

All but

5 remained vvell: of these hvo subsequently deyeloped a
mild non-suppurative cervical adenitis late in convalescence,
one an otitis media, one a transient fibrinous pleurisy and
one an acute nephritis.

Of the 48 complicated cases all

hut one were promptly and permanently cured of the specific
toxemic phase of scarlet fever as shown

~y

fall in temper-

ature, ra9id fading of the rash and prompt neutralization
of toxin in the olood.
1Hake (4) in July, 1924, reported concerning the ') se
-21-

"Intramuscular injection

of Dochez's serum as follows:

of the serum in therapeutic doses early in the disease is
followed by ra}Jid clinical cure

as evidenced by cri tical
fadin:~

fall of temperature and pulse to normal, raJ)id

the rash Hnd prom:;::>t return to a state of well being.

of
The

specific toxic substance present in the blood of patients
with scarlet fever is neutralized in vitro
serum.

~y

Dochez's

It promptly disappears from the blood stream fol-

lowing serum treatment.

~he

blood serum of scarlet fever

patients acquires the capacity to blanch the rash in scarlet
fever 7lithin a few houy's after serum treatment.

Grah8.m (25)

in usinz the Dochez serum had twenty-one patients de7elop
serum disease out of thirty-one cases.

~ost

of his patients

were given serum after exposure to scarlet fever before
symptoms had developed.
Parks (32) October, 1925, makes the following report
concernin:~

t:'le use of anti toxin:

"Scarlet fever antitoxin was first administered by
us in January, 1924.

'his was Plade possL)le throu,sh a

1

supply of serum by Dr. Dochez.

The first serum was only

moderately pbtent, and in the doses Jiven by the intra~lscular

ing.

method, the results

though sood were not strik-

In January, 1925, it was decided to give it to al-

ternate patients, and in severe cases to 3ive it intravenously.

The antitoxin most used was our own preparation

obtained from two horses that had received increasing toxin
-22-

injections for nine months and more;
fourth of the

C~lses

sent us by Doche?,.

to~i 'fe

in about one

we used a new preparation of the serum
The results of the intra'fenous injection

was so striking that the medical
1925,

~ut

~oard

. ,. ,
decided In Jdarcn.,
~

all patients havin.:s a r:tsh and a temper'3.ture

of 101 degrees F. or

hi~her,

antitoxin and to give it to

alternate patients having a temperature lower than 101 degrees F.

It was siven intravenously in all severe cases.

:he potency of the antitoxic serum was tested either
'by the Schulz-Charlton blanching test or 'lY the more accurate Dick neutrali?'ation tests of the toxin.

Its p'Jtency

ranged from 50-150 units per cuoic centimeter; that is,
1 c.c. of the serum neutralized between 5,000 and 15,000
D~ck

test skin doses of toxin.
Most of the sernm was not refined.

A')out fifty patients

ho'vever, received the refined 8oYJ.ti toxic .;10')u11n sol'Jtion.
The theralJeutic res'Jlts were =t1ike, hut re,shes occurred in
about 60 per cent after the injection of the unrefined
serum and in only
refined.

a~'Jout

30 per cent after injection of the

ihe rashes and other symptoms of serum disease

tha t did oc C'.Ir ";;ere more severe wi tn the unrefined.
serious after-effects occurred in any case,
siCKness in some was very annoyinJ.

~ut

the serl1ID

A sufficient dose

should be 3iven at the earliest possible

morne~t.

An amount

should he given i'1 the fi.rst dose to ffic-'.k-e ,cmd keep the
fluids of the body anti toxic.

:f, however, the tem)era tilre

rises after the drop, a secohd injection should be given.
-23-

1he size of the dose is influenced by the weight of the
individual and the severity of the case.

Intravenous

injections of sufficient size give the most
sults.

'';''he fluids of the

~)od~r

as sho',"ln by the Dick test.

strikin~

re-

"become qllickly antitoxic,

7his when done even an hour

or tvw afterwR,rds, is al'f\rays negative, if a sufficient
dose has beensiven, and rema.ins ne:r;ative if done later
in the disease.
The resul te from sufficiently large intramusc:Jlclr
injections are certain, 'Jut they develop more slowly.

The

Dick test is positive for from six to twelve hours after
. t
1" ar InJec
•
t Ion.
.
an In"ramuscu

T
.L

t

J

t"nen ')ec()mes neJa.GIve.
....

The results as noted at the bedside in the majority
of patients are lTery stri ki:1~~."The hi!,her the temDerature
and the more toxic the case, the more

strikin~

will be the

results if the serum is given very early in the disease.
After an intraV'enous injection in an early uncomplicated
case, the patient, as a rnle, finds within a few hours that
the throat is less sore, the mind clears, vomiting ceases,
the A<)I)eti te returns, 8.nd the temperature and pul se "oesin
to fRll.

'Jithin from six to

eL:~ht

hours,

C"t

ith a larger

a very sick patient is often conV'alescent.
dose

~iven

intra~lscularly

more slov/ly.

delirio:ls and

the same results follow, but

\,Hth ins1Jfficient dosaGe

t1'H~re

is less rapid

improvement, and the toxic symptoms may retnrn.
In 1926 Lewi s (31) reported
-24-

favora~11e

re 8'.11 t s for the

cure and reduction of complications in sc:=trlet fever by
the use intramnscnl:l,rly of anti toxin.

~re

thin'{s the intra-

venous injection is indicated only in critical oonditions.
Stovall (39) in reviewing the advances in treatment
of scarlet fever stated that the therapeutic value of antitoxin is established and constitutes the really well p~oved
advCl.'Tce in its treatr'1ent.

:a is effective in the cnre of

the toxemia of scarlet fever and

pro~ably

indirectly lowers

the incidence of complications in these cases.

He states

it should be used early in all cases of scarlet fever, hut
it is only the occasional circumstance

~hich

calls for its

use for prophylactic purposes.
In the treatment of 500 cases of scarlet fever, C11shing (9), u8in; both the Dtck

serur:1~::md

the Dochez serum

intramuscularly, states that the disease is cut short and
relief from all its early manifestations

w~cs

obtained.

J!'rom his o"bservations he t:::links it lessens the number and
severity of the comnlications and definitelv
.!-.

•

mortality of the disease.

0..'

He

~elieves

used ec'lrly in every case except

lo~ers

the

the serum should "be

one~l~1.ich

is extremely

mild.
Levy (30) in July 1926 treated 37 cases with scarlet
fever antitoxin usin1
serum.

~oth

concentrated and unconcentrated

In severe and toxic cases they used intravenous

injections and in the TIoderate cases

intra~lJscu13r

injections.

Their results show the serum to be of value as a therapeutic
-25-

meaRure.

They s ta te that serum sl10uld be

fore complications have occurred.

.:~i ven

moder~te

In

earl~T

cases give

intram~J.scularly

and in severe or toxi c, intravenously.

Also the serum

sic~neBs

is often more

scarlet fever in mild cases.
forei3n serum they
su"'Jcutaneo 1 1s1y.

~ive

be-

annoyin~

than the

2efore administerinj any

adrenalin chloride 1-1000 solution

They also Vfarm the anti toxin to body he!"tt

and transfer to a glass lner syringe before injection.
P. A. Bly (6) in 1926 reported concerning the treat-

ment of 34 scarlet fever patients

~y

serur:t and convalescent vlhole :)lood.

the use of the

Doche~

He states that the

serum appeared to ')rin,s about a more rapid improyement in
the symptoms of the toxemia, and particl)l"lrl:;T an earlier
disappearance of the exanthem.
1)la tau. and Collins in Xovem"'Jer, 1926, rel)Orted 00servations over 100 cases of sC8"rlet feverifilich were
treated with antitoxin.

These are compared

~i~h

a control

;rOllp of 100 cases si:rrml taneously observed wr'licl"l received
no serum.
were used.

71."10

of the concentrated comrnercial preparations

une made

accordin~

to Dick's method, the other

~ach

accordin3 to that of Dochez.

patient receivinJ the

antitoxin was .:;iven a sin,:,le "therapeutic H dose (10-14
c. c.) as prepared ·by the ffic:mufacturer.

All of the 8,nti toxin

wasSi ,ren intramuscularly in dosages sufficie~'1t to neu-

"

tralize from 200 to 500 thousand skin test doses of toxin.
Intravenous administration was not done because of the fear
\

of serious reactions.

Rapid hlanchin1 of positive Dick
-26-

tests was noted after the antitoxin was Jiven.
Serum react ions:

Al thou:sh there '}'lere no iJYlJTIedia te

anaphylactic reR.ctions noted, the urticaria and serum
sickness, which developed in 25 of the 100 antitoxin cases
must be considered seriously.

Eleven of these were of the

intense, recurrent type which persisted for three to five
days and caused the most extreme discomfort to the

tient.

In eight of them, there WR.S a history of toxin-antitoxin
administration fJur to fifteen "months before, and some of
the most severe reactors were in a ;roup of nurses who previously had been immunized a:;ainst diphtheria.
Toomey (42) in Decem':)er, 1926, reported the treatment
of 345 cases, 300

~)y

inj ecti ons,

a vari ety of the commerci3.1 preparati ons.

usin~~

intramuscular :mel 45 "by intrave"lous

Fifty cases were used as controls and did not receive the
serum treatment.
nThe reactions resultin; from the intramllscular injections were

compara~le

with other sera.

more serum sic'(ness than others.

SJIDe antitoxins cause

"Ii th intramuscular inj ec-

tions, the serum reactions ranged from 10 to 70 per cent:
dependent upon the antitoxin used.
vvith intramuscul(l,r

inj(~ctions,

Tise in tempere_ture.

Chills occurred even

2nd h8,d the :.1.8112.1 sh"trp

This res"ltin.; sernr.'l sj.c1<ness vms

re')ellious in nature, was

h~.,rd

to t8,>::e care of, n:'1d in

some instances was even accompanied by edema of the epi~lottis

and trachea, and

~y

persistent vonitin].
-27-

In two

~nBtances (both nurses)

the serum sic~ness was associated

w'ith ma1'ked artnritis, dyslme8., cyanosis, 8.nd edema of epiglottis.

:b'req 11entl;r, the pain

art:hri tis, overshadows +'he
t·'ne
-

- l 'leal·lon
....
C01'1P

for

~hieh

assoei:::~,ted

~7'J.ole

'.I'lith S8rum sickness

clinical picture, so that

..~ .
+.J"
t t'ne (lSBel,se
1.
causes ...'nh e lJ8..iJlenl,
,,0 1.orge,
.J..

he has been originally treated.

"7ith intravenous medication,

~e

have

~een

unfortunate.

Abon t 54 cases were inj ected, ''on t the reac ti O:lSll\Tere so
severe that we discontinued this

met~od

of treatment, hav-

ing 3 fatal cases ocenring 5 hours to 36 hours after injection."
Gordon (24) usin~ a concentrated antitoxin, prepared
by the Dick method, treating over 300 cases mentions no

difficv.l ty wi th serious reactions n,nd sa:;Ts th8t sCclrlet
fever anti toxic serum exerts
effect in

reducin~

q

favora'Jle and well marked

the severity of the febrile stage of the

disease, on the 'course '·md dura.tion of the fever, on the
extent and duration of the skin lesions, qnd on the period
of isolation.

He states there are fewer cJmplications in

pa tients receiving the serum, also a faYora,ble effect on
cor.rplications evidenced l:>y a lessened severi ty a.nd duration,
as

~ell

as incidence.

In January, 1928,
unsel,"cted cases

ey reported 465 consecutive and

occnTrin~

at the Taillard :Parker Hospi tal

in which 250 of the patients did "'lot receive anti toxin.

:-Ie

concluded that scarlet fever anti toxin is of defini te va,lue,
-28-

out th'3"t the mild 8,nd l'10der,3,tel:r sick

~)[ltients

recr;iYe 8no11::;h "benefit to w'arrant its use.

do, not

He also stated

that the serum rash is often most distressing and causes
more sufferinj than a moderate attack of the disease.
Toomey (43) in N"ovembe-r, 1923, rej)orted that the mortality rate of scarlet fever had not
use of antitoxin.

~een

lowered by the

He refers to the fact that the mortality

had dropped to its low rate

~efore

the introduction of

antitoxin and tha.t there had been no apprecia')ledecline
either in hospital mortality rate or general rate in the
years since antitoxin had been used.
Place (:)3) in February, 1928, a"1d Pritchett and Fletcher
(35) i"1 AU,sust, 1929, studyin3 the effect of a.ntitoxin stated

that it had a definite favorable effect on toxic cases of
scarlet fever but its effect on the complications were
doubtful.

Pritchett and Fletcher also stated that the ser-

um reactions are more severe than mild scarlet fever.
'Jelford (50) studied the effects of antitoxin on 492
cases of scarlet fever entering the 1funicipal Contagious
Disease llospital at ChicaJo from January to June 1928.

He

stated that scarlet fever anti,toxin seemed to exert a "beneficial effect in

lessenin~

the toxemia of scarlet fever

in 60 per cent of the cRses--classified as toxic or severe.
During the period October, 1926-1927, Craig (8) treated
500 cases of simple scarlet

fe~er,

10 cases of septic scarlet

~nd

2 cases of the toxic type of the

dise~s2.

ti ce f 011 o'vedwas to adni ni s ter sarnID, on the clay of ,,1"dmission to hospital, to every definite case of scarlet
fever of the s:unple type within the first three days of
disease.
Sera from two different companies were used, and they
in turn standardized by use of the
inJ test or the Dick test.

Schult~-Charlton

b1anch-

A dose of 10 c.c. of the con-

centrated sernm was iSiven to each case intramuscularly.
Serum reactioYls:- Ou.t of the total oL" 500

C8,888

re-

ceivinJ serum 41 per cent showed reactions at periods varying from 4-16 days after the injection.
symptoms Sive rise to alarm.

~n

In no case did the

25 per cent of these cases

there was only a rash, which lasted from a
three days in the most severe cases.

~ew hou~s

to

The remEdning 16 per

cent showed definite si;ns of serum disease: slight pyrexia,
adenitis, fleetin3 joint pains, and an urticarial eruption.
They further state that the admirlistration of antitoxic
serum within the first three days of disease produces a
favorable effect on c ounteracti.ng the spec i fie toxeFlia.

The

full therapeutic dose should be given t=tt the earliest possible moment to obtain the best results.

When

~iven ~ithin

the first three days of disease it lessens the incidence
8,nd

reduces the severi ty of sU'Jseq1Jent complications and

total period of hospitalization.
"lurton and .....ialmain (7) S.3ptef'l;)er, 1929 used antitoxin
-3Q-

in the treatment of scarlet fever patients by
injections and oqtained favorable results.
the intravenous serum was not used
I

ered

unjustifiab~e

~ecause

intra~uBcular

Tney state that
it was consid-

to expose younJ children to

R ~osBihle

fatal therapeutic risk in a disease which at the present
time is usually non-fatal.

They state that Toomey and

Dochez had three deaths wi th anaphyla.ctic symptoms out of
40 ila tients inj eqted intravenously.
Hill (26) iq October, 1929, stated the beneficial
effects that may be expected by using serum in scarlet
fever patients are a prompt subsidence of temperature, a
quicker

disappea~ance

of the rash, a lessening toxicity,

and perhaps the occurrence of a few less complications.
He also stated that its chief value is in the treatment of
severe cases.
In l\fovember 1 1929, nick and Dick (18) report from thei r
experience vii th

~carlet

feyer anti toxin that it may oe em-

played therapeuttcally with advantages in all cases of
scarlet fever as soon as the appearance of the rash
diagnosis.

sug~ests

The longer the patient goes without antitoxin,

the less benefits from it when it is
'')e wi thheld until i t

beco:!~es

~iV"en.

It should not

apparent that the a,ttack is

a severe one, but should be given in time to prevent the
development of a: severe attack.
They state that reports as to the effect of scarlet
fever antitoxin in reducing the complications are sometimes
( 31.)

~onflicting,

due to delay in administering the serum in

some cases, or to the use of poor preparations
Gelkey (23) Octoher, 1930, stated that unfortunately
t~)xin

the nel1tralize. . tion of i ts

does not 'prevent the hemol-

ytic streptococcus from further invasion.

Se)tic Tn'oeesses

are unmodified by the use of antitoxin, does not decrease
the complications or lower the mortality becanse death is
usually due to streptoc OC ell s i nvasj. on to other parts.
Tsuda (45) in April 1931 gave a:1titoxin prepared by
the Hygi eni c Research Inst i tu te, Sou th

I\i~anc:1ur ia

Haillivay

Compcmy-l c.c. of this preparation is said to neutralize

1000 sldn test doses of toxin.

l{e gave llniformily 40 c.c.

for an injection and stated that other writers are not
definite about the dosage they have used.
He further states:

":nvesti~ators

hold different

opinions in re3ard to whether the injection influences
complications.

Von J3orma:'1n stated that an injection at

an early period prevents possible complications
inj~ction

given five days after onset

more liable to complications.
tion renders

complic~tions

rna~es

~lt

an

the patients

3 enso '1 said th'l.t an injec-

less likely; however, an injec-

tion on the first day of the dise8,se does not alwetys insure
~

~atient's

not being affected by complications.

According

to Schottmuller injections reduced cases of lymp"hi'ldenitis

"b:" half.

Deicher sedd t:mt injections render complications

less inte:lse, "but it is not certain whether or not the

(32)

injection prevents

complicntio~s.

Acc)rding to Toyoda's

recent work the injection of an antitoxin seems to have
little if any effect in

preventin~

complications

a~d

to

have no effect on complications already developed in the
patient.

3uschmann also conside-red that an injection

h~.s

no preventive effect against complications."
3anks (1) in a sUYlLmary of the results in 2,430 reported cases of early uncomlllicated SC3rlet fever in which
specific streptococcus anti toxin was used shows th8.t:

(.a)

Temperature recession is usually more prompt in the serum
treated cases than in control cases.

(b)

The duration of

the eruption is shorter in the treated than in the untreated
cA.ses.

(c) Early symptom improvement is more comm;)n in the

serum-treated cases.
loc''1li7ed in those
not.

(e)

'~lho

(d) Desquamation is milder Rnd more
receive sernm than i:1 those 'J'rho d.o

Anti toxin exerts a favorable infll1ence 0'1 the

incidence of mnjor complications.
istration of serum
pentic results.

proba~ly

~ives

(f) Intravenous adminthe most striking thera-

(g) Serum reactions Ci,re a I'1et1acil1~ factor

in ab -mt ten per cent of cases Rnd can oe the cause of
death unless the most rigid precautio:1s .3.re eml)loyed.
Stevenson, Veldee, and Mitchell (3l) in the treatment
of 196 patients oeserved the therapeutic efPects of SCRrlet

84 }J3"tients constituted the control, 74

the anti toxin A ;?:ronp 8,'1d 38 cornpri sed the anti toxin B

:s:r Oup •

Antitoxin A was purchased
(33)

:a

'l,ras a concentrated seru.r.l prepared wi til 4 strains of hemolytic streptococcus,
fever patients.

ori~inqlly

isolated from scarlet

The therapeutic package

WRS

la~eled

to

contain 6,000 units of antitoxin in a volume of 15 c.c.
However, because of an allowance for deterioration, each
therapelltic dose ];iven contatned approximately 20 c.c.
and possessed an antitoxin value of about 7,200 units.
Antitoxin B was not for sale in the open market.

It

was an unconcentrated serum prepared from a single strain
of' hemolytic streptococcns

v!h~cn

had previollsly been is-

olated from a case of scarlet fever.
~ational

Test made at the

Institute of Health determined that this antitoxin,

altholl::;h unconcentrated,

CO'1 t~'d'1ed

i~l

the therapeutic dose

of 8 c.c. approximately 6,400 units of antitoxin.
The dvration of the period of eruption in the combined antitoxin-treated groups Was 4.4 days, as aJainst
6.9 days in the control group.
Apparently, the antitoxin had no influence on the
duration of the interval before desquamation began, nor
did it halTe a pronounced inflnence
period.

0'1

the desq 1 lamation

There was a definite tendency for the desquamation

to be localized and mild in character in the serum-treated
ca.ses but to be

~eneralized

aYld marked in the control

patients.
An analysis of the temperature records failed to reveal any definite febrile reduction
tration of antitoxin.
(34 )

followin~

an adminis-

serum

3xcludin~

sic~ness,

there were 75 per cent fewer
otitis !:ledia,
in the serum-

trea ted thc:J.n in the c antral 3r ouP.
66.3 per cent of the serum-treated Datients developed
serllm sickness of varyinJ de3rees of severity.
A previous injection of serum seemed to 'oe the most
imlJOrtant p"edisposin..:; cause of serum sic:Cness.
cent of those

87.2 per

tients who h:::td received a previolls i'1jec-

tion of hOTse serum in any form and 85.3

ce-:1t of t:'lose

}J<:>Y

'Nno had previously recei veel serum only in the fJrm of elilJntheria toxin-antitoxin developed serum sickness.
In the ,3rouP of patient s

\Y~lO

had rece i ved no :lrevi ous

injection of serum the total percentage of serum sickness
-c~as

40.8.

:n

this~r()np

the incidence of serum sickness

seemed to be directly influenced "0y the volnme of serum
injected, since 66.7 per cent of the patients receiving
20 c. c.

0 f

reGeivin~~

serum (anti toxin A) and 16.0 IJer cent of t:lOse
8 c.c. of serum (antitoxin TI) developed compliI

--

cations..

antitoxin over a period of 4 years.

The se

those mentioned in ':1is previo:Js report
The

ta~le

c(~ses

include

I

(19~9).

contrasts between the cases

t~eated

in 1927,

!

when no serum was used, and those of the

pre~ent
I

!

(35 )

series.

~r1\.3LE

I.

Year 1927

Yea.rs 1928-32

(ifo-seruTii)

,r

ntr8':venoli's-se

rum)
Complications of 1204
Cases of Scarlet Feve~
(I

Complications of 285
Cases of Scarlet Fever
/"' 7.-1
otitis media
o.
;0
l\!~astoidi tis
1.0
Nephritis
3.7
Arthritis
1.7
Total complications
33.0
IJIor tal i ty
1.05
Average stay in hospital 46 days

0:-4
•

0../

/0

.08
.8
0.16
5.2

.08
16.6 days.

~This comprised in the average case

perature by crisis in 6 to 12 hours,

(a)

~all of tem-

(b) disappearance

of toxaemic symptoms wlth7,eneral reeIiDs of well-being
i""l 6 to 12 hours,
aeon t

12 hours,

(c) su')sidenceof fa'lCi'll oedeMA, in

(d) fa.din; of rash in 12 to 26, hour s.
\

'f'~rhen

these effects are o'btained in any given case,

certain SUbstantial advR.ntages follov/.
of the fever restores comfort and

The rapid arrest

~rin;s

about almost irn-

Mediate return of appetite and normal Bleep.
diet is tolerated after 24 hours.
loss of normal nutrltion,
in,:;ly rapid.

8,11.d

T~ere

Ordinary

is little, if any,

comralesce'1ce is correspond-

The patient IDa,;T then l)e safely allowed up

after 4 or 5 days.
"The rapidity with which faucial oedema
even more important.
effect, and

to

~e

It appears, indeed, to

su~sides

~e

t~e

is
key

particularly associated with antitoxin

admini stered in trayen.ously.

As edema
(36 )

6U ~)S

ides, the pain

~ssociated

with swallowing is relieved, Eustachian drain-

age 1S q'lickly

allowing middle ear inflam-

re-esta~lis~ed,

mation to resolve, a"1d the flow of se'itic material to the
cervical

~lands

is checked.

'Pinally, the
Q'WJl1Ettion.
the serum

ra~id

fading of the rash prevents Jes-

Desqnamation was e'1tirely absent
vva.S

8 ..

S n r'1le if

,;i ven not later than the third d8.yo f the

disease, a'1.d modified to a fine powdering, with or w:.thout
small flakes 0'1. the h"'lJlds

~1.nd.

feet, j.f administration of

the serum 'vas delayed to the fourth or fifth day.
II Reduction
of Comnlications.
----,
. _----------------«----lIComplications were reduced to a remarkable extent
eVe!l 'vhen due a 110warJ.ce is made for the milder type of
sct3"let fever prevalent in recent years.
c::3" t ions VI"li ch did occur were of
as to leave no

ascertaina~le

J' "'h
.
1 case,
1. e "cyplca

~3hort

?er~anent

The fev\r compli-

dura ti on and so mild
damage.

-.
show1ng
a norma 1 response to intra-

venous serum treatment, shows no evident loss of nutrition,
:10 desquamation nor complications, a"1d may 1)e discflE:rged
from hospital after 8 to 10 days, or a few days longer, if
it is considered

desira~:)le

that the patient

s~10uld

in hOSl)i tal over the period of the serum rash •• fI

(37)

remain

"1.' he serum used was

a"1d Company and

out

t:hR,t~)ut

'3urrou~sh,

intravenously in adequate

:Jy

the PRxk, :i)8vis

'7ellcome and CompanY,--injected
dosa~e;

i.e., a s1n;le dose of

approximately 20 c.c. for an adult, 12-15 c.c. for a

c~ild

6ver 10 years and 10 c.c. for a small child.
Davi s serum appe::"red to have the

advantaf~e

mediate serum shock occurred in its nse.

in that no imNo anap:o.ylactic

reactions in protein--sensitive or serum sensitive persons
were met with in this series.

The thermal reactions, with

or without ri.sor,':-;(lich m;:l,J' occur about~, hour ai:ter intra-

venous i:'1jection, is in a different c:de;ory.
and does not appear dangerous.

It is cormnon

:t occ'lY'red in 'h0th maKes

of serum, the incidence varyinJ from 7 to 100 per cent, accordine; to the 'batch.

It w'as al'Ifays treated prophylactically

a"1d rarely gave rise to anxiety.

In one case, however,

(the only fatal case i"1 the series) it was associated with
convulsive twitC:hL'L;, and death occurred 12 hours after the
serum injection.
"Generally it is of the utmost importance to obtain a
se"um of proved
some reactions.

~)otency

and known to oe free from trou"ble-

Each new "batch of scarlatinal antitoxin

used for intravenous injection in scarlet f'ever should 1:Je
tested out in hospital in adequate dosage an a few cases
in ',v'Lich complete tests for ,serur.l sensi tivener~s ha,ve ':)een
made.

1I

(38)

INDICA,]IONS

lIAccording to the

experience~ained

i"1 this series of

cases, the indications for intravenous injections of antitoxin in sCB,!'let fever wOllld, except :or the rare contraindicated cases, appear to be, in order
1. T0xic scarlet fever.

o~

iMport~nce:

2. Septic scarlet fever, even

la te i"1 the di S98,se, provided tun t faue 1al edema iss till
present.

3. The severe forms of

sc~~latina

simplex;

~.

g.,

that conmonly OCCll,r in adults. 4. Defil1ite cnsesof scarlet
fe 1rer wi.th faucial inflam..mation, rasll and pyrexia, especially those treated in a hospital ward along with other
cases':

CONTRA-IHDICATIONS

ra) All cases ,;,vi th a history of asthma, eczema, hay
fever, frequent urticaria or other manifestgtions of a1-

(b) All cases that have :'lCi,d a j)Y'evious in,jection of
serum, especially within the previous two

yea~8,

except

'Nhen serum is ur ;e:'1tly incU ca ted, in wni en case de sensitization may be attempted.
(c) Cas8Fl 'vhere any test for ser'lm sensiti1reness is
llositive.
(d) Very mild cases with , little or no faucial
(39)

inflammation and li ttle or no rash."
!e~bE!.1:.9.ne:

lThe con.junctival, intradermal and scari-

fication skin test for sensitiveness to the

~atch

to he employed, may be done as a preliminary, one
undiluted serum being used for each test.
tests which can be performed in a

!'1inl~te

of serum
dr~p

of

These are simple
or two.

The;v were

employed d'lring the latter part of this investig8.tion but
no serum-sensitive indivifulal was encountered.

The first

few drops of intravenous serllm should be given as slowly as
possi 'ole,

t~lis

tec:':1nique cO:'1sti tnting a fourth test for

serum-sensitiveness; viz., the intravenous test.

In any

case of doubt as to serum sensitiveness, the intravenous
test in 1 in 10 dilution should be employed.
cedure in hospital cases is the

suhc~taneous

A useful proinjection of

1 c.c. horse ser1lID by the Wlrse, one hour before the intravenous

in.jection~

"'iTi th all new batches of serum, adrenalin should '::le

injected subcutaneonsly just before giving the serum.
This prophylactic adre'1alin may be given in all cases as
a routine, but it is, as

8,

rule, unnecessary vrhen ade-

quate experience of a particular lJatch of serum h8s 11een

:After this procedure the serum is inJected undiluted
int 0 a vein

"by

t1:1e syri nge

JTlet~lod-- be s t

us i ng

8.

short

rigid needle 'Hi th a short :)eve1, a sharp point, and
about SilO

TI. m.

'::lore.

After the injection,
(40)

the foot of the bed is raised for an

':l)11T,

being wrapped in a warm blanket, and hot

the p8.tient

~ottles

put into

the oed:'
~ttention

Joepehen (28) calls

to the fact that opin-

ions a:)out the serotherapy of sC;:-l,rlet fever are still
divided.

J oepehen l1'lade (1)serva t ions on 220 case s.

Of

these, 100 were treated with intravenous injections of
serum, :::;0 with normal horse serum, and the Jther 100 received no serotherapy.

He reaches the concl 11sion that

intravenous seroth(3rapy vii th srY!E\,ll doses fifty be recommended
and that it has advantages over the

intra~lscular

method.

However, it influences only the initial toxicosis, the
exanthem and the fever, and does not prevent complications
or reduce their severity.

For tais reason Joepehen employs

serotherapy only in the toxic and severe cases, and he
emphasizes

thc~~t

the injection should "oe nade as ea""'ly as

possi")le.
Kahn and Josey (29) are of somewhat the same opinion
in regard to Ule serum therapy.

:::n an

a~'1alysi

s of ?02

cases of sCRrlet fever in adFlts a"ld olcier childre:1, of
whom 127 received antitoxin, the report shows a definite
favorable effect on the toxic svmptoms

o~

th~

disease.

'l'hey state the hi:;h i:1cidence of disability d:Je to serum
cliserlse must lJe

wei~hed

a,::;ainst this effect.

of complications is not affected
8.1tholl~~h

by

incide:~1ce

S8rHID admini.stration

their severi ty may lJe lessened.

(41 1

The

in a study of 2,303 cases
of scarlet fever in which

88~

wer~

treated with antitoxin

of the disease Rre the early diagnosis
tion of an

adeq~w. te

a~d

the

~dministra-

8. .mo'J.nt of sC[lrlet feyer anti toxin.

Cl.n ti toxin used was a c )I'1Jnerc 1"11

C

The

O"1cen tr::l ted 8:1d reP ined

serum, standardized by means of skin tests in sllscepti'b1e
~)ersons.

Une therapeutic dose (sufficient a:1ti toxJ_11 to

neutralize 300,000 skin test doses of toxin) was
intram.uscularly in

MOS

~iven

t cases, 801 thou",.:;h in some of the

severe cases two, three, fOllr or mo"e therapeutic doses

Of the effect of anti toxin on the cli nic8"1 course of
the disease }Iunt states:
~i\Ten,

":f enouJh antitoxin has been

the typical punctate rash fadesNi tilin tW'elve to

twenty-four hours q,nd
lar flush

per~isting.

be absent/vi th:mly

fiFty

If the rash

8..

S11bcllticu-

been pres?nt for

h~s

three or fDur days, the effect of the antitoxjn on the rash
is not so stri king b11t it ha.s a tendency to run a course
somewhat simillC1. r to the r;::csh in
has not been adEinistered.
the

s~in

ca,s!~s

in 'J'hich a'1ti toxin

Corroborative evidence that

lesions are milder is shown by the fact that the

clesree of desqnamation is ma,rkedly less in:Jatients receivtn~

antitoxin,

~eing

usually

tlmes for only a few days.
ras~

s1i~ht

a~d

lasting somc-

".'Ji t:'l the disal)pearance of the

there is a marked improvement in the seneral condition
(42)

of the patient, especially

noticea~le

in toxic cqses.

Another effect of the anti toxin is the l.mmn,skino; of s11ch
complications as are already present.

ihe removal of the

toxic element of the disease makes the recoJnition and
proper treatment of early complications more certain.
In regard tJ cOI'1plications he stated (1) A l:''),r:?;e
nnm"ber of ser i ous campli CR. ti ons occurred i:1 t:ae mild ce,se s
in ""Thich anti toxin 'Has not adrcinistered.

humoer of severe cases were free from c ,)mDlications in the
series in 7rhich cmtitoxtn was administered, in contrast to
the L3er;e num-oer of severe C3,se s

1-,11.,q t

sho'Ned c ornpli cat ions

in the series in which antitoxin was not

~d~inistered.

7, ,
(

t,...J

!

A sma.ll num'ier of complications occurred '7hen the a:1ti toxLn
V\To'loS

given durin.:;

t~'1efirst

two or three days of the disen.se.

Illustrative Cases of Septic and Semi-septic Types (1).

admitted

'7. :;t., Mal e ,
~he

c~ild

was drowsy and

temperature 102.? de.~rees F.: .lJ111se 116:
:lllJuminuria.

lO-28-30~

notified

extre~ely

T2S"D.

2B:

ill:

sli:~ht

Ins?ection of the throat showed intense

oedemF\. of fauces and. soft l)al:),te l[vi t:::l extensive sloushing

111ceration of tonsils, pill';:,.rs a'1d Hyula, and copious
mue 0 -purulent naso-pharyn~eal d i sc'1ar3:e.
(43)

'the cerirj, cal

:r18.nds were grei\tly enlar.;ed, pD.rtic'1htrly on the right
side, .qncl there

W'.3>S

some peri;landular oedema.i'he ton:;ue

was of the Hred stra;',berry!l type.
was present, faintly marxed
on the limbs, 'Nhere it

Vh'cS

O~'1

A

sC~Hlet

fe'.Ter rash

the tr'Jnk 'Jut mOY'e defini te

of the

II

!Jlotchy·t ChclT"lcter so

often associated with sepsis.

The case appeared to be a

typical scarlatinal anginosa.

Treqtment on admission:

7 c.c. scarlatinal antitoxin intravenously, and 12,000
v.ni ts diphtheria anti toxin intramuscularly, toi;ether wi th
routine irrigation of
8 7 1'"a"o

proved to lJe

oedema

7iT(l,S

f8,11Oe8.

nega~ive

Hext

mor'1h1:~

the throat

for diphtheri"), 1)8.oilli:

f8..'lcial

';1;rea ted reduced ,bu t as t'.:le cIli Id was still '[ery

ill an additional 17 c.c. of scarlatinal antitoxin was
~he

given intravenously.

same

e7enin~

the general condi-

tion sho'wed ma"ked improvement, f3,'lCi,"1.1 oedema had almost
disappeared,

althou~h

there was deep and extensive ulcer-

.

ation; temp. 97.4 deJrees F., pulse 108.

Next morning

10-30-30 fa,11cj.al oedema was nil (36 hours) 'lYld '1asal disCht1.rge had cle'1.red IIp.

J:'er:1perature remained normal from

24 hours after the first close of serum, exce)t for a rise
to 100 desrees F. on -l:;he f onrt'1 da'l after

adT~i

was albumin-free 48 hours after aclmission.
ulcer:Jtion lvas practically
was present from the
mission.

sixt~L

h:~aled

in 6

s s ion.

tTI' ine

rhe fWlcial

da~ts.

to the eleventh day

A SerH:r:1 rash
aft(~rad-

The child was allowed 11.p on the fifteenth da;'t

8.Yl(1 was disc:!iar.::;ed well after 25 da;'Ts in hospi tal.

(44 )

Cp,se II

Senttc type sixth

__ .. _ _ _ _ .., _ _ _ _ _ _ _ ._.A..--_ _ ~_ ...._~._......._ _ _ _

H.
ill~

da~T.

_ _ _ _ _ _ _ _ ...,.;... _ _

G., meole, age 5 ye,:,rs; admitted

3-l5-'~9i

-restlessj delirious! sel'li-cc)matose.

wn,s ex-':,reme, the

f8,1JCeS

pR.]illae; rash

Fa,ucLlloeder:lcl,

Y'1ee+-tng j_n the middle

pnrrtlent nasal dischar::;e; cerlTical

faded~

gr83ely

,~1':v'1ds

line~

copious

enlarged to form

temp.

p';lse uncountq,hle; cY'3,no;:;is rrlarked_ at times wi th impr:rcepti~le

~ulse.

Treqtment:

20 c.c. scarla:i1al antitoxin

intra'lrenollsly; stiY'1'llants (caMphor 90nd e:~er)

3ravely

oxy~en,

and

ill and not fully conscious; rash petechial in

character; crepitations at bases of lunJs; oedema of throat
sli,;htly reduced, allo'vin:; \)re'lthing to be e8sier: profuse
p'lrnlent di schar~e from nose

~md

piece of

throat;

necrosed tissue douched out from throat; bowel washed out
-rrith

~;ood

results,

On 11arch 17, 36 hours after admission,

temperature was normal, pul se 106; conrli ti on

1'1!C1S

:;re"1._ tly

improved; child could anS7ler que sti ons; 6landular swelling
greatly reduced; colour and :;)1).1 se (pit e

~;ood.

24 hours later

he was qlli te comforta,l)le; fancial and periglandlllar oedem8,
had disal)peared, althol1;h lllceration was still
a

lar-~e

~-tnd

ell. Berete :;land could 0e felton left r;ide of neck

a few sI'laller-;lands- on ri;ht side.

a~ain

exte~'lsi'Te~

Ter:rperat )re rose
1

on third eveninJ after admission and reI'lained elevated
( 45)

~hi1e

~l~~d

a

a~sce8s

was incised on March
ri~ht

slowly formed on left side; tais
2~nd

side was incised on

Rnd R similar gland abscess on
~arch

25th.

The child was dis~.

charged well after 41 days in hospital.
two

severel~r

B. In these

septic cases, otitis media did not develop.

C. B., male, aee 4 vears: '-i.dmi tted ,3-21-30
·~vi

th mar1{ecl p;:tl10r and

to,1silzi
~)oth

,

restle,'s.'1ess~

palate 8.nd uvulC'", vlTith

~

child ill

i:1te':1se oecleY'1a of

pult~:tceons

exudate covetr"lg

t ansi 1 s, pro fu se pUTulent net. sal cii sCflc~rge, and marked

adeni tis; !Ired strawberr:"r il tongue

~

faded Y'ermants of

temp. 100.2 de--;rees J?, pulse 1:56.
20 c.c.

scarl~tinal

fauces, etc.

rash~

Trerl.tf"lent on adr:,ission:

antitoxia intravenously, irrigation of

Next morning general condition excellent;
di
fauci8.l oedema nractica1lv
- - ..
~

-

e~. re(l

;

deep 8.nd extr:>nsiITe ulcerated area involv-in; ';'lhDle of tonsil,
pillars, and uvula and covered with pus; adenitis reduced;
throa t

swab ne ~s8.t i ye for eli})h theria 'Jae il1i •

remained normal

throu-~hout

this a

cla~r,

Tel"'lperR.ture

then rose

and ::;r8.dllally fell to norp'tal oJ;ring next 6 days,

8_~8.in,
'Jl~lile

the

ulcerated s]1rfaces healed; the general condition remained
:sood

throu:~hout

this period.

This case desTJamated t;,'-pi-

cally and was discharged well after 38 days in hospital.

seventeel1th da'- . ')f scarlet fever, which had follo'lVed
of the forearm and

a~domen

on 1-13-32.

~)nrns

On admission, there

. "ense InJ
. . ec t 1. 0~1 ana' 1
was In
08CAemR of fanc2S,palate and
~.

pharynx, the tonsil meeting, and the '/lho Ie qr2a

~)e

i ne 11,1-

cerated Rnd covered with pus; profuse purulent nasal dischar,;e Ftnd marl<E-?6 r:ervi cal adeni ti s; resp1 rat ions rapid
and noisy; dyspnoea and dysphagia

~rom

obstruction in throat;

the dlild was desqnarrJ.atin:r typic8.,1, "ritll flakeF'· or slein on
I

"'emp. 101 rle'~recs J?, pulse 140.

-iven,on admission owing

~o

the late stage of the disease.

On 2-7-32, the child vIas 0 bvi oHslYsoing
was

c~ntinuous,

0erum was not

and feedirtg was almost

d')'vvn~1ill:

impQssi~le;

dyspnoea
oedema,

i

ulcer$tion and discharge was, if anythinj, worse.

The

!

prognfsis was grave, cl,Y1d it was decided to try the effect
I

of intravenons antitoxin, 20 c.c. of ,r(nich

',7"1,8

gJ_ven on

Six honrs later, iml)rOVement was observed ~ the
child: sat IIp Emd talked for the first time.

In 36 hours

I

i

a-f'ter! the injection of serum, the fO.u.cial 'yedema '18,0. ::11most

~ll

disappeared; there was no dyspnoea and swallowing

~as e~sier; the throat

was much cleaner and

extensively

I

~e

]Jlc

ed area cO'11d

easily seen for t"1e fir:::.t time;

per

e remained normal f or the next 24 [lOUr s, then ro se
owing to otit's medin.

Left ear discharzed on

(47)

Febru8,ry 13th.

Serum rash 7vas trou\)lesorne

'1nd right ear di schar;ed on Febr 118,ry

C) 7th.

0"],

:b'e 1Jrnar;;T 16th

7he ra l ) Cial vl-

rieratioh was healed on February 14th, ? days after administration

o~

serum.

The child was

dischar~ed

well on March

23rd, after 50 days in hospital.

K. C., female, a?;e 19 years; admitted 10-0-30, in
sixth day of the
Hlcer~lted;

disease~

fauces oedematons 2tndextensi'lely

profnse post-nasal pnrulent disch8,rge; TnB,rked

adenitis; "red strawberry"

ton~ue;

la t inal eru:Dti on pre 8e~'1t.

The si 1"'1 ,cras lP1comf or t('l.ble, had

remnants of faded scar-

not slept for several ni,;hts, and had considera"ble pain on
57ralloYling.

''':emlJ. 101.2 :F., lYulse 110.

scarlatinal antitoxin intravenoHsly.

'rreatment

~~O

CoCo

Next morning she felt

"ever so much betteI"l; fauctn,l oedema was rnarkedl1T red1Jced;
there

'[vEl.S

no pain on 6'][9,110wing, al P10T;h the fallcial 1)lce1'-

+"1
8.:,

\flaS

still exte"1sive:

on

~ture

<Hl en i tis ron c h red u c e d •

became normal on October 11th and

O~

October 13th the

f8,1).ces "vere q11i te hea,led and she vms allo",,"led UP.
quamated freely.

.J.eT1per-

She des-

She was discharged well on Octoher 21st,

after 15 days in hospital.

(48)

COKCLUSIONS

1. Scarlet fever antitoxin exerts a favorahle influence on the clinical course of the disease.
evidenced by a lessened severity of
the disease, on the conree

~,nd

t~e

T"his is

febrile stage of

durqtion of the fever, and

on the extent and duration of the skin lesions.
2. Antitoxin exerts a favorable influence on the incidence of major complications.
3. Most of the complications that occur in patients

-

who have recei~red anti toxin, appear to be in LlOse who have
received it relatively late in the disease.
4. Serious cJmplications often develop froM mild cases
of scarlet fever treated without antitoxin.
5. Intravenous administration of the serum pro"b'1,oly
gives the most

strikin~~

therapeutic

res~llts.

If

8

~ood

preparation of' serum is used, intrayenons medication is
apparently just as safe as the intrar1nscnl;"1,r.
6. Serum reactions are a menacinJ factor in many of
the cases, depending in part upon the serum used and in
part upon the sensitivity of the

~atients.

Ev~r~

patient

should be tested for sensitivity before the serum is given.
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